JHEC(SH:600273) ZHESHANG SECURITIES·2025-08-06 01:11Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company's revenue for H1 2025 reached 5.006 billion yuan, a year-on-year increase of 8.31%, driven by significant price increases in key products such as fatty alcohols [2][3] - The net profit attributable to shareholders for H1 2025 was 581 million yuan, up 9.64% year-on-year, benefiting from the recovery in downstream demand for sulfonated pharmaceutical products and improved price differentials in caustic soda [2][3] - The company is focusing on shareholder returns, maintaining a dividend payout ratio around 50% and actively repurchasing shares [4] Financial Performance Summary - For H1 2025, the company achieved a gross profit margin of 17.42%, an increase of 0.49 percentage points year-on-year, and a net profit margin of 11.60%, up 0.13 percentage points year-on-year [1] - In Q2 2025, the company reported revenue of 2.645 billion yuan, a year-on-year increase of 4.55% and a quarter-on-quarter increase of 12.06% [1] - The average return on equity for H1 2025 was 5.62%, an increase of 0.35 percentage points year-on-year [1] Future Outlook - The company is expanding its fatty alcohol production capacity with a new project expected to contribute to earnings in the second half of 2025 [3] - The price differential for fatty alcohols has significantly improved, with an average price difference of 4,206 yuan/ton in Q3 2025, a quarter-on-quarter increase of 31.83% [3] - Revenue projections for 2025-2027 are estimated at 10.596 billion, 11.957 billion, and 13.050 billion yuan, respectively, with net profits expected to reach 1.216 billion, 1.395 billion, and 1.574 billion yuan [9]